Efficacy of Vedolizumab (VDZ) by Disease Extension in Ulcerative Colitis (UC)

被引：0
|
作者：
Michetti, Pierre [1 ,2 ]
Braegger, Fiona [3 ]
Kempf, Christian [3 ]
Allez, Matthieu [4 ]
机构：
[1] CHU Vaudois, Gastroenterol La Source Beaulieu, Lausanne, Switzerland
[2] CHU Vaudois, Div Gastroenterol, Lausanne, Switzerland
[3] Takeda Pharmaceut Int AG, Zurich, Switzerland
[4] Univ Paris 07, Hop St Louis, AP HP, Dept Gastroenterol & Hepatol,INSERM,UMRS 1160, Paris, France
来源：
SWISS MEDICAL WEEKLY | 2018年 / 148卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
G38
引用
收藏
页码：22S / 22S
页数：1
相关论文
共 50 条
  • [41] Comparing the Efficacy and Safety of Adalimumab and Vedolizumab in Treating Moderate to Severe Crohn's Disease and Ulcerative Colitis
    Merza, Nooraldin
    Nawras, Yusuf
    Saab, Omar
    Dahiya, Dushyant Singh
    Ahmed, Zohaib
    Ranabothu, Meghana
    Boujemaa, Safa
    Hassan, Mona
    Kobeissy, Abdallah
    Lilley, Kirthi
    GASTROENTEROLOGY RESEARCH, 2023, 16 (06) : 289 - 306
  • [42] Vedolizumab Long-term Efficacy and Safety in the Treatment of ulcerative Colitis and Crohn's Disease in Adults
    不详
    VISCERAL MEDICINE, 2017, 33 (05) : 391 - 391
  • [43] Good efficacy and safety of vedolizumab in Crohn's disease and ulcerative colitis in a real-world scenario
    Zingone, Fabiana
    Barberio, Brigida
    Compostella, Federico
    Girardin, Giulia
    D'Inca, Renata
    Marinelli, Carla
    Marsilio, Ilaria
    Lorenzon, Greta
    Savarino, Edoardo Vincenzo
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2020, 13
  • [44] Vedolizumab vs adalimumab for ulcerative colitis
    Feetham, Laura
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2019, 4 (05): : 337 - 337
  • [45] Combination of vedolizumab and immunomodulators in ulcerative colitis
    Pinton, P.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 (12) : 3556 - 3556
  • [46] Is ulcerative colitis (UC) a disease of primary mast cell origin?
    Raithel, M
    Winterkamp, S
    Schwab, D
    Hochberger, J
    Georg, E
    GASTROENTEROLOGY, 1999, 116 (04) : A801 - A801
  • [47] Review of vedolizumab for the treatment of ulcerative colitis
    Michelle SY Lau
    Her Hsin Tsai
    World Journal of Gastrointestinal Pharmacology and Therapeutics, 2016, (01) : 107 - 111
  • [48] The safety of vedolizumab for the treatment of ulcerative colitis
    Novak, Gregor
    Hindryckx, Pieter
    Khanna, Reena
    Jairath, Vipul
    Feagan, Brian G.
    EXPERT OPINION ON DRUG SAFETY, 2017, 16 (04) : 501 - 507
  • [49] Vedolizumab trough concentrations and histological remission in Ulcerative Colitis: Results from the LOVE-UC study
    Hanzel, J.
    Baert, F.
    Lowenberg, M.
    Ferrante, M.
    Bossuyt, P.
    Hoentjen, F.
    Franchimont, D.
    Palatka, K.
    Peeters, H.
    Mookhoek, A.
    de Hertogh, G.
    Clasquin, E.
    Vermeire, S.
    D'Haens, G.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 625 - 626
  • [50] UC for UC: Ursodiol chemoprevention for ulcerative colitis - Comment
    Brentnall, T
    INFLAMMATORY BOWEL DISEASES, 2003, 9 (05) : 339 - 339
12345